Finance

Beta
Lists
ORNBV:HEL
Orion Oyj Class B
€71.60
+0.99%
(+0.70) 1D
May 29, 6:29:37 PM GMT+3  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ORNBV...
Open
€70.90
High
€71.65
Low
€70.80
Mkt. cap
10.05B
Avg. vol.
175.62K
Volume
820.95K
Dividend
2.51%
Quarterly dividend
€0.45
Ex-dividend date
Oct 15, 2025
P/E ratio
19.02
52-wk high
€75.30
52-wk low
€56.50
EPS
€3.76
Shares outstanding
109.61M
No. of employees
4K
Open
€70.90
High
€71.65
Low
€70.80
Mkt. cap
10.05B
Avg. vol.
175.62K
Volume
820.95K
Dividend
2.51%
Quarterly dividend
€0.45
Ex-dividend date
Oct 15, 2025
P/E ratio
19.02
52-wk high
€75.30
52-wk low
€56.50
EPS
€3.76
Shares outstanding
109.61M
No. of employees
4K
News stories
From sources across the web
Profile
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland. Orion's class A and B shares are listed on the Helsinki Stock Exchange. Wikipedia
About Orion Oyj Class B
CEOLiisa Hurme
Employees4.13K
FoundedSep 21, 1917
Headquarters-
SectorPharmaceutical industry
Websiteorionpharma.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
416.50M
423.20M
695.30M
417.70M
Cost of goods sold
168.10M
169.00M
186.60M
163.70M
Cost of revenue
168.10M
169.00M
186.60M
163.70M
Research and development expenses
49.10M
49.80M
70.60M
48.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
96.70M
84.60M
110.30M
91.90M
Operating expense
143.70M
133.20M
180.40M
139.30M
Total operating expenses
311.80M
302.20M
367.00M
303.00M
Operating income
104.70M
121.00M
328.30M
114.70M
Other non operating income
-100.00K
-
-500.00K
100.00K
EBT including unusual items
103.40M
120.40M
327.10M
113.40M
EBT excluding unusual items
103.40M
120.40M
327.30M
113.40M
Income tax expense
20.90M
24.40M
66.60M
23.00M
Effective tax rate
20.21%
20.27%
20.36%
20.28%
Other operating expenses
-2.10M
-1.20M
-500.00K
-900.00K
Net income
82.50M
96.00M
260.50M
90.40M
Net profit margin
19.81%
22.68%
37.47%
21.64%
Earnings per share
0.59
0.68
1.85
0.64
Interest and investment income
-
-
4.60M
-
Interest expense
-1.20M
-600.00K
-5.40M
-1.40M
Net interest expenses
-1.20M
-600.00K
-800.00K
-1.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
118.70M
135.10M
336.50M
130.40M
Gain or loss from assets sale
-
-
100.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer